GRDN: J. Goldman discloses 656,860 shares (2.9%) in 13G/A Amend. No. 1
J. Goldman & Co., L.P. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 656,860 shares of Guardian Pharmacy Services, Inc. common stock, representing 2.9% of the class as of the event date 09/30/2025.
Rhea-AI Filing Summary
J. Goldman & Co., L.P. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 656,860 shares of Guardian Pharmacy Services, Inc. common stock, representing 2.9% of the class as of the event date 09/30/2025.
The filing is jointly made by J. Goldman & Co., L.P., J. Goldman Capital Management, Inc., and Jay G. Goldman. Each reports 0 shares with sole voting or dispositive power and 656,860 shares with shared voting and shared dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership did J. Goldman report in GRDN on this Schedule 13G/A?
Which entities and individuals are listed as reporting persons for GRDN?
What are the voting and dispositive powers disclosed for the GRDN position?
What is the event date referenced in the GRDN Schedule 13G/A?
Does the filing indicate a passive investment intent for GRDN?
What class and CUSIP does the GRDN filing cover?
AI-generated analysis. How Rhea-AI works. Not financial advice.